TherapeuticsMD (TXMD) Earnings Analysis
TherapeuticsMD (TXMD) next reports earnings on 2026-08-17, consensus EPS -5.5 USD. Last quarter (2026-03-30) it missed with EPS -0.0535 USD vs 0.04 USD est (-233.8%). It has beaten estimates in 0/2 recent quarters (0%). Trailing P/E 131.17.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does TXMD next report earnings?
| Next earnings date | 2026-08-17 |
|---|---|
| Consensus EPS estimate | -5.5 USD |
| Revenue estimate | 0.02B |
TXMD earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-03-30 | -0.0535 USD | 0.04 USD | -233.8% | Miss |
| 2025-11-12 | 0.01313 USD | n/a | n/a | n/a |
| 2024-08-12 | -0.09 USD | 0.03 USD | -400% | Miss |
Beat rate: 0/2 (0%) over reported quarters with consensus data.
TXMD valuation and analyst view
| Trailing P/E | 131.17 |
|---|---|
| Trailing EPS | 0.01547 USD |
| Price / book | 0.87 |
| Dividend yield | 0.00% |
| Market cap | 0.02B |
| Analyst consensus | Buy (4 buy / 3 hold / 1 sell) |
Related research pages
Frequently asked questions
When is TherapeuticsMD (TXMD)'s next earnings date?
TherapeuticsMD is next scheduled to report on 2026-08-17, with a consensus EPS estimate of -5.5 USD and revenue estimate of 0.02B.
Did TXMD beat earnings last quarter?
In its 2026-03-30 report, TXMD posted EPS of -0.0535 USD versus a 0.04 USD estimate — a miss of 233.8%.
What is TXMD's earnings track record?
Over the last 2 reported quarters with consensus data, TXMD beat estimates 0 times (0%).
What is TXMD's current P/E ratio and EPS?
TXMD trades at a trailing P/E of 131.17 on trailing EPS of 0.015465698980473475 USD.
What do analysts rate TXMD?
Analyst consensus is "Buy" across 8 ratings (0 strong buy, 4 buy, 3 hold, 1 sell, 0 strong sell).